118 related articles for article (PubMed ID: 24060905)
1. Effects of the thioredoxin-1 inhibitor PX-12 on blood-brain barrier permeability in the early stage of focal cerebral ischemia.
Chi OZ; Barsoum S; Grayson J; Liu X; Weiss HR
Pharmacology; 2013; 92(3-4):175-81. PubMed ID: 24060905
[TBL] [Abstract][Full Text] [Related]
2. Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex.
Chi OZ; Hunter C; Liu X; Weiss HR
Neurol Res; 2005 Dec; 27(8):864-8. PubMed ID: 16354548
[TBL] [Abstract][Full Text] [Related]
3. Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia.
Chi OZ; Hunter C; Liu X; Weiss HR
Neurol Res; 2008 Apr; 30(3):288-93. PubMed ID: 17767813
[TBL] [Abstract][Full Text] [Related]
4. Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia.
Chi OZ; Hunter C; Liu X; Weiss HR
Exp Neurol; 2007 Mar; 204(1):283-7. PubMed ID: 17188266
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic Preconditioning Increases Blood-Brain Barrier Disruption in the Early Stages of Cerebral Ischemia.
Chi OZ; Mellender SJ; Barsoum S; Liu X; Weiss HR
Curr Neurovasc Res; 2017; 14(1):26-31. PubMed ID: 27823555
[TBL] [Abstract][Full Text] [Related]
6. The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging.
Jordan BF; Runquist M; Raghunand N; Gillies RJ; Tate WR; Powis G; Baker AF
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):529-36. PubMed ID: 15701837
[TBL] [Abstract][Full Text] [Related]
7. Effects of GABA(A) receptor blockade on regional cerebral blood flow and blood-brain barrier disruption in focal cerebral ischemia.
Chi OZ; Hunter C; Liu X; Chi Y; Weiss HR
J Neurol Sci; 2011 Feb; 301(1-2):66-70. PubMed ID: 21094956
[TBL] [Abstract][Full Text] [Related]
8. Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia.
Chi OZ; Hunter C; Liu X; Weiss HR
Pharmacology; 2008; 82(1):38-42. PubMed ID: 18434762
[TBL] [Abstract][Full Text] [Related]
9. Blood -brain barrier disruption was less under isoflurane than pentobarbital anesthesia via a PI3K/Akt pathway in early cerebral ischemia.
Chi OZ; Mellender SJ; Kiss GK; Liu X; Weiss HR
Brain Res Bull; 2017 May; 131():1-6. PubMed ID: 28238830
[TBL] [Abstract][Full Text] [Related]
10. Effects of blockade of ionotropic glutamate receptors on blood-brain barrier disruption in focal cerebral ischemia.
Liu X; Hunter C; Weiss HR; Chi OZ
Neurol Sci; 2010 Dec; 31(6):699-703. PubMed ID: 20217443
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin decreased blood-brain barrier permeability in control but not in diabetic rats in early cerebral ischemia.
Chi OZ; Kiss GK; Mellender SJ; Liu X; Weiss HR
Neurosci Lett; 2017 Jul; 654():17-22. PubMed ID: 28625574
[TBL] [Abstract][Full Text] [Related]
12. Effects of endothelin-1 on blood-brain barrier permeability during focal cerebral ischemia in rats.
Chi OZ; Liu X; Weiss HR
Exp Brain Res; 2001 Nov; 141(1):1-5. PubMed ID: 11685406
[TBL] [Abstract][Full Text] [Related]
13. Effects of metabotropic glutamate receptor stimulation on blood-brain barrier permeability during focal cerebral ischemia.
Liu X; Chi OZ; Weiss HR
Neurochem Res; 2004 Oct; 29(10):1857-62. PubMed ID: 15532541
[TBL] [Abstract][Full Text] [Related]
14. Effects of exogenous excitatory amino acid neurotransmitters on blood-brain barrier disruption in focal cerebral ischemia.
Chi OZ; Hunter C; Liu X; Weiss HR
Neurochem Res; 2009 Jul; 34(7):1249-54. PubMed ID: 19127429
[TBL] [Abstract][Full Text] [Related]
15. Effects of VEGF on the blood-brain barrier disruption caused by hyperosmolarity.
Chi OZ; Hunter C; Liu X; Tan T; Weiss HR
Pharmacology; 2008; 82(3):187-92. PubMed ID: 18708733
[TBL] [Abstract][Full Text] [Related]
16. Effects of 17beta-estradiol on blood-brain barrier disruption in focal ischemia during GABA(A) receptor inhibition.
Chi OZ; Hunter C; Liu X; Weiss HR
Horm Metab Res; 2005 Apr; 37(4):209-13. PubMed ID: 15952079
[TBL] [Abstract][Full Text] [Related]
17. The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma.
Baker AF; Dragovich T; Tate WR; Ramanathan RK; Roe D; Hsu CH; Kirkpatrick DL; Powis G
J Lab Clin Med; 2006 Feb; 147(2):83-90. PubMed ID: 16459166
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p70 ribosomal S6 kinase 1 (S6K1) by PF-4708671 decreased infarct size in early cerebral ischemia-reperfusion with decreased BBB permeability.
Chi OZ; Kiss GK; Mellender SJ; Liu X; Liu S; Jacinto E; Weiss HR
Eur J Pharmacol; 2019 Jul; 855():202-207. PubMed ID: 31063769
[TBL] [Abstract][Full Text] [Related]
19. Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats.
Chi OZ; Barsoum S; Grayson J; Hunter C; Liu X; Weiss HR
Pharmacology; 2012; 89(5-6):333-8. PubMed ID: 22678129
[TBL] [Abstract][Full Text] [Related]
20. Effects of rapamycin pretreatment on blood-brain barrier disruption in cerebral ischemia-reperfusion.
Chi OZ; Mellender SJ; Barsoum S; Liu X; Damito S; Weiss HR
Neurosci Lett; 2016 May; 620():132-6. PubMed ID: 27037216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
